{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:27:36Z","timestamp":1777454856041,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T00:00:00Z","timestamp":1495670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1017\/s1041610217000886","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T04:58:10Z","timestamp":1495688290000},"page":"1525-1534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Association between advanced glycation end-products and functional performance in Alzheimer's disease and mixed dementia"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6376-9712","authenticated-orcid":false,"given":"Hans","family":"Drenth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sytse U.","family":"Zuidema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim P.","family":"Krijnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Bautmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cees","family":"van der Schans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Hobbelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1017\/S1041610217000886_bb0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1463-1326.2006.00595.x","article-title":"Advanced glycation endproducts: what is their relevance to diabetic complications","volume":"9","author":"Ahmed","year":"2007","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1017\/S1041610217000886_bb0015","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1017\/S1041610217000886_bb0020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1477-7525-2-52","article-title":"Ability to perform activities of daily living is the main factor affecting quality of life in patients with dementia","volume":"2","author":"Andersen","year":"2004","journal-title":"Health and Quality of Life Outcomes"},{"key":"10.1017\/S1041610217000886_bb0025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-0838.2005.00464.x","article-title":"Enzymic and non-enzymic cross-linking mechanisms in relation to turnover of collagen: relevance to aging and exercise","volume":"15","author":"Avery","year":"2005","journal-title":"Scandinavian Journal of Medicine & Science in Sports"},{"key":"10.1017\/S1041610217000886_bb0030","series-title":"Alzheimer Disease Overview","author":"Pagon","year":"1993"},{"key":"10.1017\/S1041610217000886_bb0035","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1586\/ern.11.57","article-title":"Loss of motor function in preclinical Alzheimer's disease","volume":"11","author":"Buchman","year":"2011","journal-title":"Expert Review of Neurotherapeutics"},{"key":"10.1017\/S1041610217000886_bb0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/09638288809164103","article-title":"The Barthel ADL Index: a reliability study","volume":"10","author":"Collin","year":"1988","journal-title":"International Disability Studies"},{"key":"10.1017\/S1041610217000886_bb0045","doi-asserted-by":"crossref","unstructured":"Drenth H. , ZuidemaS., KrijnenW., BautmansI., van der SchansC. and HobbelenH. (2017). Advanced glycation end-products are associated with the presence and severity of paratonia in early stage Alzheimer's disease. Journal of the American Medical Directors Association, in press.","DOI":"10.1016\/j.jamda.2017.04.004"},{"key":"10.1017\/S1041610217000886_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s11556-016-0163-1","article-title":"The contribution of advanced glycation end product (AGE) accumulation to the decline in motor function","volume":"13","author":"Drenth","year":"2016","journal-title":"European Review of Aging and Physical Activity: Official Journal of the European Group for Research into Elderly and Physical Activity"},{"key":"10.1017\/S1041610217000886_bb0055","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/09638280010029930","article-title":"Contractures in orthopaedic and neurological conditions: a review of causes and treatment","volume":"23","author":"Farmer","year":"2001","journal-title":"Disability and Rehabilitation"},{"key":"10.1017\/S1041610217000886_bb0060","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"Journal of Psychiatric Research"},{"key":"10.1017\/S1041610217000886_bb0065","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/0891988716686835","article-title":"Hierarchical decline of the initiative and performance of complex activities of daily living in dementia","volume":"30","author":"Giebel","year":"2017","journal-title":"Journal of Geriatric Psychiatry and Neurology"},{"key":"10.1017\/S1041610217000886_bb0070","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2753.2007.00917.x","article-title":"Assessing walking speed in clinical research: a systematic review","volume":"14","author":"Graham","year":"2008","journal-title":"Journal of Evaluation in Clinical Practice"},{"key":"10.1017\/S1041610217000886_bb0075","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1017\/S1041610207006424","article-title":"Diagnosing paratonia in the demented elderly: reliability and validity of the paratonia assessment instrument (PAI)","volume":"20","author":"Hobbelen","year":"2008","journal-title":"International Psychogeriatrics\/IPA"},{"key":"10.1017\/S1041610217000886_bb0080","series-title":"Het Meten Van Problemen met Zelfredzaamheid op Verzorgend en Huishoudelijk Gebied met de GARS: Een Handleiding","author":"Kempen","year":"1993"},{"key":"10.1017\/S1041610217000886_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2012.02.018","article-title":"Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective","volume":"317","author":"Li","year":"2012","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1017\/S1041610217000886_bb0090","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2307\/2533554","article-title":"Sample size calculations for studies with correlated observations","volume":"53","author":"Liu","year":"1997","journal-title":"Biometrics"},{"key":"10.1017\/S1041610217000886_bb0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11556-008-0032-7","article-title":"Involvement of advanced glycation end products in the pathogenesis of diabetic complications: the protective role of regular physical activity","volume":"5","author":"Magelhaes","year":"2008","journal-title":"European Review of Aging and Physical Activity"},{"key":"10.1017\/S1041610217000886_bb0100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000338233","article-title":"Executive function and activities of daily living in Alzheimer's disease: a correlational meta-analysis","volume":"33","author":"Martyr","year":"2012","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1017\/S1041610217000886_bb0105","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00125-004-1451-2","article-title":"Simple non-invasive assessment of advanced glycation endproduct accumulation","volume":"47","author":"Meerwaldt","year":"2004","journal-title":"Diabetologia"},{"key":"10.1017\/S1041610217000886_bb0110","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1471-2458-10-176","article-title":"The psychometric properties of three self-report screening instruments for identifying frail older people in the community","volume":"10","author":"Metzelthin","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1017\/S1041610217000886_bb0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/1574890110666151104120039","article-title":"Basic and clinical research against advanced glycation end products (AGEs): new compounds to tackle cardiovascular disease and diabetic complications","volume":"10","author":"Nenna","year":"2015","journal-title":"Recent Advances in Cardiovascular Drug Discovery"},{"key":"10.1017\/S1041610217000886_bb0120","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/10739680600618918","article-title":"Effect of inflammation on the aging microcirculation: impact on skeletal muscle blood flow control","volume":"13","author":"Payne","year":"2006","journal-title":"Microcirculation"},{"key":"10.1017\/S1041610217000886_bb0125","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/nure.12141","article-title":"Effect of advanced glycation end product intake on inflammation and aging: a systematic review","volume":"72","author":"Puyvelde","year":"2014","journal-title":"Nutrition Reviews"},{"key":"10.1017\/S1041610217000886_bb0130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1515\/CCLM.2011.079","article-title":"Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease","volume":"49","author":"Rahmadi","year":"2011","journal-title":"Clinical Chemistry and Laboratory Medicine: CCLM\/FESCC"},{"key":"10.1017\/S1041610217000886_bb0135","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000107594","article-title":"Symptoms of preclinical dementia in general practice up to five years before dementia diagnosis","volume":"24","author":"Ramakers","year":"2007","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1017\/S1041610217000886_bb0140","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","article-title":"The global deterioration scale for assessment of primary degenerative dementia","volume":"139","author":"Reisberg","year":"1982","journal-title":"The American Journal of Psychiatry"},{"key":"10.1017\/S1041610217000886_bb0145","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2522\/ptj.20080258","article-title":"Test-retest reliability and minimal detectable change scores for the timed \u201cup & go\u201d test, the six-minute walk test, and gait speed in people with Alzheimer disease","volume":"89","author":"Ries","year":"2009","journal-title":"Physical Therapy"},{"key":"10.1017\/S1041610217000886_bb0150","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neubiorev.2010.08.009","article-title":"Understanding higher level gait disturbances in mild dementia in order to improve rehabilitation: \u201clast in-first out","volume":"35","author":"Scherder","year":"2011","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1017\/S1041610217000886_bb0155","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1111\/j.1532-5415.2011.03597.x","article-title":"The identification of frailty: a systematic literature review","volume":"59","author":"Sternberg","year":"2011","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1017\/S1041610217000886_bb0160","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/gerona\/glt155","article-title":"Serum carboxymethyl-lysine, disability, and frailty in older persons: the Cardiovascular Health Study","volume":"69","author":"Whitson","year":"2014","journal-title":"The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences"},{"key":"10.1017\/S1041610217000886_bb0165","unstructured":"World Health Organisation (2014). The Anatomical Therapeutic Chemical Classification System with Defined Daily Doses (ATC\/DDD). Available at: http:\/\/www.who.int\/classifications\/atcddd\/en\/ [Accessed September 1, 2014]."}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224017435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224017435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610217000886","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:33:40Z","timestamp":1762353220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224017435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1041610224017435"],"URL":"https:\/\/doi.org\/10.1017\/s1041610217000886","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between advanced glycation end-products and functional performance in Alzheimer's disease and mixed dementia","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610217000886","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 International Psychogeriatric Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}